Related references
Note: Only part of the references are listed.Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
I. Zlobec et al.
BRITISH JOURNAL OF CANCER (2008)
Androgen receptor regulates CD168 expression and signaling in prostate cancer
Shi-Lung Lin et al.
CARCINOGENESIS (2008)
RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
Sindy Sohr et al.
CELL CYCLE (2008)
Filling the mosaic of p53 actions p53 represses RHAMM expression
Samuel Godar et al.
CELL CYCLE (2008)
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis
Inti Zlobec et al.
CLINICAL CANCER RESEARCH (2008)
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells
Sara R. Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells
V Assmann et al.
JOURNAL OF PATHOLOGY (2001)
Share Paper
